Signed Into Law
Signed May 27, 2025Effective 2025-09-01
SB1236

Regular Session

Relating to the relationship between pharmacists or pharmacies and health benefit plan issuers or pharmacy benefit managers.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who SB1236 Affects

Regulatory Priority: critical

Significant regulatory changes (effective 2025-09-01). Review with your legal and compliance teams to understand implications.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about SB1236

Q

What does Texas SB1236 do?

SB1236 fundamentally restructures the contractual relationship between Pharmacy Benefit Managers (PBMs)/Health Issuers and Pharmacies by prohibiting unilateral "adverse material changes" to contracts without written mutual agreement. This legislation voids "amendment-by-notice" practices and severely restricts financial recoupment for clerical errors during audits, shifting significant leverage to network pharmacies.

Q

Who authored SB1236?

SB1236 was authored by Texas Senator Bryan Hughes during the Regular Session.

Q

When was SB1236 signed into law?

SB1236 was signed into law by Governor Greg Abbott on May 27, 2025.

Q

Which agencies enforce SB1236?

SB1236 is enforced by Texas Department of Insurance.

Q

How significant are the changes in SB1236?

The regulatory priority for SB1236 is rated as "critical". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of SB1236?

The cost impact of SB1236 is estimated as "medium". This may vary based on industry and implementation requirements.

Q

What topics does SB1236 address?

SB1236 addresses topics including electronic information systems, health care providers, insurance, insurance--health & accident and pharmacies & pharmacists.

Q

What are the key dates for SB1236?

Key dates for SB1236: Effective date is 2025-09-01. Rulemaking: Commissioner may adopt rules to implement Chapter 1369, specifically regarding ID card identifiers and contract disclosures. (None specified in text). Consult with legal counsel regarding applicability.

Q

What are the penalties under SB1236?

SB1236 establishes the following penalties: civil penalty of Contract provision voided for Unilateral adverse material changes to pharmacy contracts by PBMs are void and unenforceable.; civil penalty of Contract provision voided for Failure to include specific opt-out notices with proposed adverse material changes renders the change void.; administrative penalty of Recoupment limitation for PBMs/Issuers may not recoup drug costs (only dispensing fees) for clerical errors that result in overpayment.. Consult with legal counsel for specific applicability to your situation.

Q

Which Texas businesses are affected by SB1236?

SB1236 primarily affects healthcare providers and medical facilities, insurance companies and financial institutions. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026